Epidermolysis Bullosa Recruiting Phase 2 Trials for Tacrolimus (DB00864)

Also known as: EPIDERMOLYSIS BULLOSA / Koebner's disease

IndicationStatusPhase
DBCOND0028939 (Epidermolysis Bullosa)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02582775MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCsTreatment